Skip to main content
Top
Published in: AIDS and Behavior 6/2012

01-08-2012 | Original Paper

Correlates and Contexts of US Injection Drug Initiation Among Undocumented Mexican Migrant Men Who Were Deported from the United States

Authors: Angela M. Robertson, Remedios Lozada, Robin A. Pollini, Gudelia Rangel, Victoria D. Ojeda

Published in: AIDS and Behavior | Issue 6/2012

Login to get access

Abstract

Preventing the onset of injection drug use is important in controlling the spread of HIV and other blood borne infections. Undocumented migrants in the United States face social, economic, and legal stressors that may contribute to substance abuse. Little is known about undocumented migrants’ drug abuse trajectories including injection initiation. To examine the correlates and contexts of US injection initiation among undocumented migrants, we administered quantitative surveys (N = 309) and qualitative interviews (N = 23) on migration and drug abuse experiences to deported male injection drug users in Tijuana, Mexico. US injection initiation was independently associated with ever using drugs in Mexico pre-migration, younger age at first US migration, and US incarceration. Participants’ qualitative interviews contextualized quantitative findings and demonstrated the significance of social contexts surrounding US injection initiation experiences. HIV prevention programs may prevent/delay US injection initiation by addressing socio-economic and migration-related stressors experienced by undocumented migrants.
Literature
3.
go back to reference Tedaldi EM, Hullsiek KH, Malvestutto CD, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn community programs for clinical research on AIDS. Clin Infect Dis. 2003;36(10):1313–7.PubMedCrossRef Tedaldi EM, Hullsiek KH, Malvestutto CD, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn community programs for clinical research on AIDS. Clin Infect Dis. 2003;36(10):1313–7.PubMedCrossRef
4.
go back to reference Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(12):1226–33.PubMedCrossRef Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(12):1226–33.PubMedCrossRef
5.
go back to reference Magis-Rodriguez C, Gayet C, Negroni M, et al. Migration and AIDS in Mexico: an overview based on recent evidence. J Acquir Immune Defic Syndr. 2004;37(Suppl 4):S215–26.PubMed Magis-Rodriguez C, Gayet C, Negroni M, et al. Migration and AIDS in Mexico: an overview based on recent evidence. J Acquir Immune Defic Syndr. 2004;37(Suppl 4):S215–26.PubMed
6.
go back to reference Magis-Rodriguez C, Lemp G, Hernandez MT, Sanchez MA, Estrada F, Bravo-Garcia E. Going north: Mexican migrants and their vulnerability to HIV. J Acquir Immune Defic Syndr. 2009;51(Suppl 1):S21–5.PubMed Magis-Rodriguez C, Lemp G, Hernandez MT, Sanchez MA, Estrada F, Bravo-Garcia E. Going north: Mexican migrants and their vulnerability to HIV. J Acquir Immune Defic Syndr. 2009;51(Suppl 1):S21–5.PubMed
7.
go back to reference Chavez LR. Shadowed lives: undocumented immigrants in American society. 2nd ed. Belmont: Wadsworth; 1998. p. 240. Chavez LR. Shadowed lives: undocumented immigrants in American society. 2nd ed. Belmont: Wadsworth; 1998. p. 240.
8.
go back to reference Valdez A, Cepeda A. The relationship of ecological containment and heroin practices. In: Thomas YF, Richardson D, Cheung I, editors. Geography and drug addiction. Dordrecht: Springer; 2008. p. 159–73.CrossRef Valdez A, Cepeda A. The relationship of ecological containment and heroin practices. In: Thomas YF, Richardson D, Cheung I, editors. Geography and drug addiction. Dordrecht: Springer; 2008. p. 159–73.CrossRef
9.
go back to reference Arbona C, Olvera N, Rodriguez N, Hagan J, Linares A, Wiesner M. Acculturative stress among documented and undocumented Latino immigrants in the United States. Hisp J Behav Sci. 2010;32(3):362–84.CrossRef Arbona C, Olvera N, Rodriguez N, Hagan J, Linares A, Wiesner M. Acculturative stress among documented and undocumented Latino immigrants in the United States. Hisp J Behav Sci. 2010;32(3):362–84.CrossRef
10.
go back to reference Apostolopoulos Y, Sonmez S, Kronenfeld J, Castillo E, McLendon L, Smith D. STI/HIV risks for Mexican migrant laborers: exploratory ethnographies. J Immigr Minor Health. 2006;8(3):291–302.PubMedCrossRef Apostolopoulos Y, Sonmez S, Kronenfeld J, Castillo E, McLendon L, Smith D. STI/HIV risks for Mexican migrant laborers: exploratory ethnographies. J Immigr Minor Health. 2006;8(3):291–302.PubMedCrossRef
11.
go back to reference Brouwer KC, Lozada R, Cornelius WA, et al. Deportation along the US–Mexico border: its relation to drug use patterns and accessing care. J Immigr Minor Health. 2009;11(1):1–6.PubMedCrossRef Brouwer KC, Lozada R, Cornelius WA, et al. Deportation along the US–Mexico border: its relation to drug use patterns and accessing care. J Immigr Minor Health. 2009;11(1):1–6.PubMedCrossRef
12.
go back to reference Strathdee SA, Lozada R, Ojeda VD, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690.PubMedCrossRef Strathdee SA, Lozada R, Ojeda VD, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690.PubMedCrossRef
13.
go back to reference Department of Homeland Security. 2009 Yearbook of Immigration Statistics [Internet]. Washington, DC: Department of Homeland Security, Office of Immigration Statistics. 2010. http://www.dhs.gov. Accessed 30 Nov 2011. Department of Homeland Security. 2009 Yearbook of Immigration Statistics [Internet]. Washington, DC: Department of Homeland Security, Office of Immigration Statistics. 2010. http://​www.​dhs.​gov. Accessed 30 Nov 2011.
14.
go back to reference Slevin P. Deportation of illegal immigrants increases under Obama administration. Washington Post. 2010;26(Sect A):01. Slevin P. Deportation of illegal immigrants increases under Obama administration. Washington Post. 2010;26(Sect A):01.
15.
go back to reference Department of Homeland Security. INA: ACT 212: general clauses of aliens ineligible to receive visas and ineligible for admission; waivers of inadmissibility [Internet]. Washington, DC: Department of Homeland Security, Office of Citizenship and Immigration Services. 2001. http://www.uscis.gov. Accessed 30 Nov 2011. Department of Homeland Security. INA: ACT 212: general clauses of aliens ineligible to receive visas and ineligible for admission; waivers of inadmissibility [Internet]. Washington, DC: Department of Homeland Security, Office of Citizenship and Immigration Services. 2001. http://​www.​uscis.​gov. Accessed 30 Nov 2011.
16.
go back to reference National Migration Institute. [Monthly bulletin of migration statistics 2010: repatriation of Mexicans from the United States; Internet]. Mexico DF (Mexico): Secretaria de Gobernacion, Insituto Nacional de Migracion. 2010. http://www.inm.gob.mx. Accessed 30 Nov 2011. National Migration Institute. [Monthly bulletin of migration statistics 2010: repatriation of Mexicans from the United States; Internet]. Mexico DF (Mexico): Secretaria de Gobernacion, Insituto Nacional de Migracion. 2010. http://​www.​inm.​gob.​mx. Accessed 30 Nov 2011.
17.
go back to reference Ojeda VD, Robertson AM, Hiller SP, et al. A qualitative view of drug use behaviors of Mexican male injection drug users deported from the United States. J Urban Health. 2011;88(1):104–17.PubMedCrossRef Ojeda VD, Robertson AM, Hiller SP, et al. A qualitative view of drug use behaviors of Mexican male injection drug users deported from the United States. J Urban Health. 2011;88(1):104–17.PubMedCrossRef
18.
go back to reference National Institute of Statistics and Geography. [Population and Housing Census 2010; Internet]. Mexico DF (Mexico): Instituto Nacional de Estadística y Geographía. 2011. http://www.censo2010.org.mx. Accessed 30 Nov 2011. National Institute of Statistics and Geography. [Population and Housing Census 2010; Internet]. Mexico DF (Mexico): Instituto Nacional de Estadística y Geographía. 2011. http://​www.​censo2010.​org.​mx. Accessed 30 Nov 2011.
19.
go back to reference Bucardo J, Brouwer KC, Magis-Rodriguez C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005;79(3):281–93.PubMedCrossRef Bucardo J, Brouwer KC, Magis-Rodriguez C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005;79(3):281–93.PubMedCrossRef
20.
go back to reference Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27.PubMedCrossRef Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27.PubMedCrossRef
21.
go back to reference Strathdee SA, Fraga WD, Case P, et al. “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005;82(3 Suppl 4):iv58–73.PubMedCrossRef Strathdee SA, Fraga WD, Case P, et al. “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005;82(3 Suppl 4):iv58–73.PubMedCrossRef
22.
go back to reference Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):11–9.CrossRef Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):11–9.CrossRef
23.
go back to reference Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.PubMedCrossRef Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.PubMedCrossRef
24.
go back to reference Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993;9(3):255–62.PubMedCrossRef Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993;9(3):255–62.PubMedCrossRef
25.
go back to reference Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34(1):180–7.PubMedCrossRef Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34(1):180–7.PubMedCrossRef
26.
go back to reference Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis. 2000;182(6):1588–94.PubMedCrossRef Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis. 2000;182(6):1588–94.PubMedCrossRef
27.
go back to reference Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999;15(7):597–601.PubMedCrossRef Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999;15(7):597–601.PubMedCrossRef
28.
go back to reference Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–26.PubMedCrossRef Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–26.PubMedCrossRef
29.
go back to reference Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737–42.PubMedCrossRef Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737–42.PubMedCrossRef
30.
go back to reference van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317(7156):433–7.PubMedCrossRef van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317(7156):433–7.PubMedCrossRef
31.
go back to reference Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis. 1996;28(1):27–9.PubMedCrossRef Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis. 1996;28(1):27–9.PubMedCrossRef
32.
go back to reference Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program. Br J Addict. 1992;87(3):493–8.PubMedCrossRef Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program. Br J Addict. 1992;87(3):493–8.PubMedCrossRef
33.
go back to reference Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67.PubMedCrossRef Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67.PubMedCrossRef
34.
go back to reference Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large US city. Drug Alcohol Depend. 2007;88(2–3):182–7.PubMedCrossRef Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large US city. Drug Alcohol Depend. 2007;88(2–3):182–7.PubMedCrossRef
35.
go back to reference Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997;92(11):1457–65.PubMedCrossRef Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997;92(11):1457–65.PubMedCrossRef
36.
go back to reference Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9.PubMedCrossRef Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9.PubMedCrossRef
37.
go back to reference Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005;95(4):689–95.PubMedCrossRef Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005;95(4):689–95.PubMedCrossRef
38.
go back to reference Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116(Suppl 1):136–45.PubMedCrossRef Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116(Suppl 1):136–45.PubMedCrossRef
39.
go back to reference Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr. 2003;32(1):86–93.PubMedCrossRef Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr. 2003;32(1):86–93.PubMedCrossRef
40.
go back to reference Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66(2):189–98.PubMedCrossRef Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66(2):189–98.PubMedCrossRef
41.
go back to reference Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.PubMedCrossRef Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.PubMedCrossRef
42.
go back to reference Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847–60.PubMedCrossRef Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847–60.PubMedCrossRef
43.
go back to reference Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.PubMedCrossRef Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.PubMedCrossRef
44.
go back to reference Sanchez J, Chitwood DD, Koo DJ. Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective. J Urban Health. 2006;83(5):896–910.PubMedCrossRef Sanchez J, Chitwood DD, Koo DJ. Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective. J Urban Health. 2006;83(5):896–910.PubMedCrossRef
45.
go back to reference Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York city: current status and prognoses. J Psychoactive Drugs. 1997;29(4):375–91.PubMedCrossRef Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York city: current status and prognoses. J Psychoactive Drugs. 1997;29(4):375–91.PubMedCrossRef
46.
go back to reference Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy. 2009;20(3):277–82.PubMedCrossRef Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy. 2009;20(3):277–82.PubMedCrossRef
47.
go back to reference Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4:8.PubMedCrossRef Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4:8.PubMedCrossRef
48.
go back to reference Sherman SG, Smith L, Laney G, Strathdee SA. Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002;13:113–20.CrossRef Sherman SG, Smith L, Laney G, Strathdee SA. Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002;13:113–20.CrossRef
49.
go back to reference Lankenau SE, Wagner KD, Jackson Bloom J, Sanders B, Hathazi D, Shin C. The first injection event: differences among heroin, methamphetamine, cocaine, and ketamine initiates. J Drug Issues. 2010;40(2):241–62.PubMedCrossRef Lankenau SE, Wagner KD, Jackson Bloom J, Sanders B, Hathazi D, Shin C. The first injection event: differences among heroin, methamphetamine, cocaine, and ketamine initiates. J Drug Issues. 2010;40(2):241–62.PubMedCrossRef
50.
go back to reference Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23.PubMedCrossRef Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23.PubMedCrossRef
51.
go back to reference van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994;139(12):1153–63.PubMed van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994;139(12):1153–63.PubMed
52.
go back to reference Valdez A, Cepeda A, Neaigus A, Russell A. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008;19(6):442–9.PubMedCrossRef Valdez A, Cepeda A, Neaigus A, Russell A. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008;19(6):442–9.PubMedCrossRef
53.
go back to reference Valdez A, Neaigus A, Kaplan C, Cepeda A. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors). Drug Alcohol Depend. 2011;114(2–3):233–6.PubMed Valdez A, Neaigus A, Kaplan C, Cepeda A. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors). Drug Alcohol Depend. 2011;114(2–3):233–6.PubMed
54.
go back to reference Cornelius WA. Interviewing undocumented immigrants: methodological reflections based on fieldwork in Mexico and the US. Int Migr Rev. 1982;16(2):378.PubMedCrossRef Cornelius WA. Interviewing undocumented immigrants: methodological reflections based on fieldwork in Mexico and the US. Int Migr Rev. 1982;16(2):378.PubMedCrossRef
55.
go back to reference Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193–201.PubMedCrossRef Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193–201.PubMedCrossRef
56.
go back to reference Gil AG, Vega WA. Latino drug use: scope, risk factors, and reduction strategies. In: Aguirre-Molina M, Molina CW, Zambrana RE, editors. Health issues in the Latino community. San Francisco: Jossey-Bass; 2001. p. 436–40. Gil AG, Vega WA. Latino drug use: scope, risk factors, and reduction strategies. In: Aguirre-Molina M, Molina CW, Zambrana RE, editors. Health issues in the Latino community. San Francisco: Jossey-Bass; 2001. p. 436–40.
57.
go back to reference Strathdee SA, Lozada R, Pollini RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr. 2008;47(3):369–76.PubMedCrossRef Strathdee SA, Lozada R, Pollini RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr. 2008;47(3):369–76.PubMedCrossRef
58.
go back to reference Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
59.
go back to reference Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009;36(12):750–6.PubMedCrossRef Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009;36(12):750–6.PubMedCrossRef
60.
go back to reference Creswell JW, Plano Clark VL, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. p. 209–40. Creswell JW, Plano Clark VL, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. p. 209–40.
61.
go back to reference Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. Thousand Oaks: Sage; 2007. p. 296. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. Thousand Oaks: Sage; 2007. p. 296.
62.
go back to reference Volz E, Wejnert C, Degani I. Respondent-driven sampling analysis tool (RDSAT), version 5.6. Ithaca: Cornell University; 2007. Volz E, Wejnert C, Degani I. Respondent-driven sampling analysis tool (RDSAT), version 5.6. Ithaca: Cornell University; 2007.
63.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.CrossRef Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.CrossRef
64.
go back to reference Muhr T. ATLAS.ti, version 5.0. Berlin: Scientific Software; 2005. Muhr T. ATLAS.ti, version 5.0. Berlin: Scientific Software; 2005.
65.
go back to reference Onwuegbuzie AJ, Teddlie C. A framework for analyzing data in mixed methods resarch. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. p. 351–83. Onwuegbuzie AJ, Teddlie C. A framework for analyzing data in mixed methods resarch. In: Tashakkori A, Teddlie CB, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. p. 351–83.
66.
go back to reference Wagner KD, Davidson PJ, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Policy. 2011;23(1):54–61.PubMedCrossRef Wagner KD, Davidson PJ, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Policy. 2011;23(1):54–61.PubMedCrossRef
67.
go back to reference O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83–8.PubMedCrossRef O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83–8.PubMedCrossRef
68.
go back to reference Robertson AM, Vera AY, Gallardo M, et al. Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico. Am J Addict. 2010;19(4):357–63.PubMed Robertson AM, Vera AY, Gallardo M, et al. Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico. Am J Addict. 2010;19(4):357–63.PubMed
69.
go back to reference Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–83.PubMedCrossRef Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–83.PubMedCrossRef
70.
go back to reference Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94(5):355–9.PubMed Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94(5):355–9.PubMed
71.
go back to reference Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113(Suppl 1):151–9.PubMed Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113(Suppl 1):151–9.PubMed
73.
go back to reference Cheng Y, Sherman SG, Srirat N, et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct J. 2006;14(3):10.CrossRef Cheng Y, Sherman SG, Srirat N, et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct J. 2006;14(3):10.CrossRef
74.
go back to reference Clatts MC, Colon-Lopez V, Giang le M, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010;87(2):278–91.PubMedCrossRef Clatts MC, Colon-Lopez V, Giang le M, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010;87(2):278–91.PubMedCrossRef
75.
go back to reference Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90.PubMedCrossRef Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90.PubMedCrossRef
76.
go back to reference Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990;7(1):1–10.PubMedCrossRef Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990;7(1):1–10.PubMedCrossRef
77.
go back to reference Pantin H, Coatsworth JD, Feaster DJ, et al. Familias Unidas: the efficacy of an intervention to promote parental investment in Hispanic immigrant families. Prev Sci. 2003;4(3):189–201.PubMedCrossRef Pantin H, Coatsworth JD, Feaster DJ, et al. Familias Unidas: the efficacy of an intervention to promote parental investment in Hispanic immigrant families. Prev Sci. 2003;4(3):189–201.PubMedCrossRef
78.
go back to reference Coatsworth JD, Pantin H, Szapocznik J. Familias Unidas: a family-centered ecodevelopmental intervention to reduce risk for problem behavior among Hispanic adolescents. Clin Child Fam Psychol Rev. 2002;5(2):113–32.PubMedCrossRef Coatsworth JD, Pantin H, Szapocznik J. Familias Unidas: a family-centered ecodevelopmental intervention to reduce risk for problem behavior among Hispanic adolescents. Clin Child Fam Psychol Rev. 2002;5(2):113–32.PubMedCrossRef
79.
go back to reference Prendergast ML. Interventions to promote successful re-entry among drug-abusing parolees. Addict Sci Clin Pract. 2009;5(1):4–13.PubMedCrossRef Prendergast ML. Interventions to promote successful re-entry among drug-abusing parolees. Addict Sci Clin Pract. 2009;5(1):4–13.PubMedCrossRef
80.
go back to reference Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–68.PubMedCrossRef Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–68.PubMedCrossRef
Metadata
Title
Correlates and Contexts of US Injection Drug Initiation Among Undocumented Mexican Migrant Men Who Were Deported from the United States
Authors
Angela M. Robertson
Remedios Lozada
Robin A. Pollini
Gudelia Rangel
Victoria D. Ojeda
Publication date
01-08-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0111-z

Other articles of this Issue 6/2012

AIDS and Behavior 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine